Scarica l'app Stockscreener
39.72
0.18%
0.07
Precedente Chiudi:
$39.65
Aprire:
$39.25
Volume 24 ore:
425.36K
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.83B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-86.35
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
+0.28%
1M Prestazione:
-7.43%
6M Prestazione:
-8.65%
1 anno Prestazione:
+45.55%
Intervallo 1D:
$39.25
$40.05
Intervallo di 1 settimana:
$38.80
$40.50
Portata 52W:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
39.72 | 1.83B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Omnicell (OMCL) Introduces Central Med Automation Service - MSN
Martin & Co. Inc. TN Sells 10,302 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Empowered Funds LLC Makes New $388,000 Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Medication Management System Market Future Business - openPR
Rice Hall James & Associates LLC Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Nigeria
Central Fill Pharmacy Automation Market Poised for Booming - openPR
Global Automated Dispensing Systems Market Size, Share, - openPR
Shaker Investments LLC OH Invests $550,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 699,925 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem - Simply Wall St
Omnicell's (NASDAQ:OMCL) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
IBD Rating Upgrades: Omnicell Shows Improved Technical Strength - MSN
Wall Street Analysts Think Omnicell (OMCL) Could Surge 29.03%: Read This Before Placing a Bet - MSN
Omnicell Q4 Earnings: Ignore The Short Term Noise (NASDAQ:OMCL) - Seeking Alpha
Exponential Growth Expected for Automated IV Pharmacy - openPR
Omnicell’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Omnicell (NASDAQ:OMCL) Shares Gap Down After Earnings Miss - MarketBeat
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises - Yahoo Finance
Omnicell (NASDAQ:OMCL) Issues FY 2025 Earnings Guidance - MarketBeat
Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Omnicell, Inc. Just Beat EPS By 47%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Omnicell (NASDAQ:OMCL) Releases Q1 2025 Earnings Guidance - MarketBeat
Omnicell's (OMCL) Buy Rating Reaffirmed at Benchmark - MarketBeat
Omnicell projects $1.105M to $1.155M revenue growth in 2025 with XT Amplify momentum - MSN
Omnicell (NASDAQ:OMCL) Issues Quarterly Earnings Results, Misses Estimates By $0.12 EPS - MarketBeat
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q4 2024 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Omnicell Reports Strong Q4 2024 Financial Results - TipRanks
Omnicell: Q4 Earnings Snapshot - Danbury News Times
Omnicell Q4 earnings beat, but stock falls on weak guidance - MSN
Omnicell earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Omnicell Inc (OMCL) Q4 2024 Earnings: EPS of $0.34 Beats Estimat - GuruFocus.com
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations By Stock Story - Investing.com Canada
Omnicell: Q4 Earnings Snapshot -February 06, 2025 at 07:11 am EST - Marketscreener.com
Omnicell Reports Q4 2024 Non-GAAP Net Income Of $28 Million Or $0.60 Per Share - Marketscreener.com
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations - Yahoo Finance
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
9.30%
2.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):